YCC Developmental Therapeutics Research Program: “Mutant-selective AKT1 inhibition via lysine targeting and neo-zinc chelation” presented by Gregory Craven
Speakers
Speakers are to be announced.
Contact
Admission
Free
Event Type
Lectures and Seminars